CTOs on the Move

Mashgin

www.mashgin.com

 
At Mashgin, we are developing the future of checkout experiences. We aim to reduce the friction between customer desires and their ability to be on their way.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Mashgin raised $62.5M on 05/09/2022

Similar Companies

911 Enterprises

911 Enterprises is a Mission Viejo, CA-based company in the Software and Internet sector.

Medfusion

Medfusion is a patient engagement platform dedicated to facilitating the relationship between physicians and patients. Our technology combined with our industry expertise enables healthcare facilities to operate more efficiently and effectively so you can get back to focusing on the quality of care being delivered to your patients. What makes us different? We are more than just a technology company – we are your partners in navigating the future of healthcare.

Viastore

For over 40 years, viastore systems has been a leading international provider of automated material handling solutions including AS/RS (automated storage and retrieval systems, shuttle and conveyor systems, warehouse management systems software, material flow and process controls, and integrated SAP logistics solutions. The company has almost 400 employees worldwide and annual sales of over $135 Million. North American operations are located in Grand Rapids, MI.

Kabira Technologies

Kabira Technologies, Inc. is a San Mateo, CA-based company in the Software and Internet sector.

InnovHeart

InnovHeart s.r.l., with operations in Colleretto Giacosa (Italy) and Poway (CA-USA), develops the Saturn System, a transcatheter mitral valve replacement (TMVR) platform intended to treat patients suffering from mitral valve disease. Saturn`s unique design allows the clinician to accurately deliver the prosthesis in the anatomically correct position, providing a stable and durable anchorage and sealing to the implant site. The system`s sub-annular ring affords inverse remodeling of the mitral annulus, and the low profile of the prosthesis ensures unimpeded flow from the left ventricle after implantation.